000 | 01243 a2200349 4500 | ||
---|---|---|---|
005 | 20250515153051.0 | ||
264 | 0 | _c20090413 | |
008 | 200904s 0 0 eng d | ||
022 | _a1532-6535 | ||
024 | 7 |
_a10.1038/clpt.2008.234 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFriberg, L E | |
245 | 0 | 0 |
_aAn agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment. _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _cApr 2009 |
||
300 |
_a409-17 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aDrug Interactions _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoxazoles _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aPaliperidone Palmitate |
650 | 0 | 4 |
_aProlactin _xagonists |
650 | 0 | 4 |
_aPyrimidines _xblood |
650 | 0 | 4 |
_aRisperidone _xblood |
700 | 1 | _aVermeulen, A M | |
700 | 1 | _aPetersson, K J F | |
700 | 1 | _aKarlsson, M O | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 85 _gno. 4 _gp. 409-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2008.234 _zAvailable from publisher's website |
999 |
_c18559881 _d18559881 |